Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | ARGX | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.01 | 775.00 | 849.54 | ||
| High | 108.59 | 781.46 | 852.24 | ||
| Low | 107.27 | 770.00 | 828.28 | ||
| Latest | 108.24 | 779.67 | 844.41 | ||
| Change | +0.11 | -2.71 | -2.85 | ||
| % Change | +0.10% | -0.35% | -0.34% | ||
| Volume | 191,230,496 | 615,200 | 245,300 | ||
| 20-Day Average Volume | 16,188,930 | 813,480 | 344,080 | ||
| Previous Close | 108.13 | 782.38 | 847.26 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 770.98 | 837.47 | ||
| 20-Day Raw Stochastic | 63.25% | 57.68% | 47.49% | ||
| 20-Day Relative Strength | 64.69 | 53.82 | 52.18 | ||
| Weighted Alpha | +46.30 | +24.25 | +35.40 | ||
| Today's Opinion | 100% Buy | 100% Buy | 64% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | -0.51% since 02/12/26 | +1.30% since 02/12/26 | ||
| Low | 107.27 on 11/20/19 | 770.00 on 02/20/26 | 817.20 on 02/13/26 | ||
| High | 110.53 on 11/14/19 | 815.00 on 02/17/26 | 852.83 on 02/17/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | +6.25% since 01/20/26 | +4.29% since 01/20/26 | ||
| Low | 102.40 on 10/21/19 | 731.51 on 02/02/26 | 802.65 on 01/21/26 | ||
| High | 110.70 on 11/13/19 | 815.00 on 02/17/26 | 881.89 on 01/27/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | +5.79% since 11/20/25 | -8.07% since 11/20/25 | ||
| Low | 93.41 on 08/23/19 | 691.86 on 12/09/25 | 770.67 on 01/12/26 | ||
| High | 110.70 on 11/13/19 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +31.92% since 08/20/25 | +27.75% since 08/20/25 | ||
| Low | 89.08 on 07/23/19 | 541.00 on 10/13/25 | 658.60 on 08/22/25 | ||
| High | 110.70 on 11/13/19 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 82,426,712 | 52,254,616 | ||
| Shares Outstanding, K | 711,714 | 105,720 | 61,883 | ||
| Annual Sales | 15,281,000,000 | 14,342,900,000 | 2,252,040,000 | ||
| Annual Net Income | 4,046,000,000 | 4,504,900,000 | 833,040,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,884,300,000 | 1,151,340,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 844,600,000 | 344,260,000 | ||
| 60-Month Beta | 1.41 | 0.40 | 0.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 11.44 on 01/30/26 | 5.18 on 10/30/25 | ||
| Latest Earnings Date | 01/30/20 | 05/05/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 21.68 | 64.78 | ||